Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Cliniques Universitaires Saint-Luc · Institut Gustave Roussy · +28 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
199
total citations
- FWCI
- 94.57
- Percentile
- 100%
- References
- 26
Citations per year
Authors
190Topics & keywords
Topics
Keywords
- Medicine
- Pembrolizumab
- Chemoradiotherapy
- Placebo
- Regimen
- Head and neck squamous-cell carcinoma
- Clinical endpoint
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.